3' sequence identity is dispensable for the established function of a mammalian miRNA in vivo.
Introduction
MicroRNAs (miRNAs) are well-established regulators of mRNA stability and translation (Bartel 2018) . The discovery that hundreds of distinct miRNAs are expressed in animals (Lagos-Quintana et al. 2001; Lau et al. 2001; Lee and Ambros 2001) , and the subsequent finding that, unlike plant miRNAs, bilaterian animal miRNAs were only rarely predicted to base pair to their regulatory targets with full complementarity (Mansfield et al. 2004) , raised the challenge of predictively identifying miRNA targets via computational analysis. Seminal work by the Burge and Bartel laboratories revealed that the most highly conserved pairing between miRNAs and mRNA 3' untranslated regions (UTRs) was predicted to occur between nucleotides 2-8 of mammalian miRNAs and their mRNA targets (Lewis et al. 2003) . This finding was broadly incorporated into a generation of miRNA target prediction algorithms, and several subsequent studies corroborated these initial predictions by showing that the interaction between previously established miRNA-mRNA pairs was not only dependent upon the seed sequence, but, moreover, independent of or only marginally reliant on non-seed sequence (Brennecke et al. 2005; Doench and Sharp 2004; Kloosterman et al. 2004; Lai et al. 2005; Lim et al. 2005 ).
The first unbiased identification of bona fide miRNA/mRNA target pairs by physical association of Argonaute proteins with mRNA (Chi et al. 2009 ) largely corroborated the predictions of these existing algorithms. However, this work also catalogued a significant proportion of Argonaute/mRNA interactions in which no seed-complementary microRNA response elements (MREs) could be identified. This finding has been consistently replicated by more recent work utilizing variations and refinements of the initial HITS-CLIP method, including methodologies that identify miRNA/mRNA pairing by crosslinking and thus direct physical association (Broughton et al. 2016; Hafner et al. 2010; Helwak et al. 2013; Loeb et al. 2012; Moore et al. 2015) . This more recent body of literature has supported the notion that various degrees of base pairing between miRNA 3' sequences and associated mRNA targets is the rule, rather than the exception. Curiously, ~20% of miRNA/mRNA interactions in these latter analyses are consistently characterized as seed-independent.
A functional role for 3' pairing has also recently been corroborated in vitro in mammalian cells and in vivo in C. elegans (Broughton et al. 2016; Jeong et al. 2017; Zhang et al. 2015) . The collective implication of these studies is that the 3' region of a given miRNA may confer an important but as-yet-undefined role in determining the target spectrum (and thus function) of the miRNA. This notion would partially explain the strict evolutionary conservation within non-seed sequences of many mature miRNAs (Griffiths-Jones 2004; Lim et al. 2003) . However, this question has not previously been genetically addressed in vivo in a mammalian system. We thus constructed a "flipped" murine allele of mir-146a (mir-146a 3'F ) in which the sequence of the 3' half of mature miR-146a was exchanged with that of its complementary strand sequence in the pre-miRNA hairpin. Mice deficient for mir-146a are hypersensitive to lipopolysaccharide (LPS) challenge and greatly predisposed to the development of hyperimmunity and myelodysplasia (Boldin et al. 2011) . Closely following the workflow initially described for the characterization of mir-146a-deficient mice (and utilizing the line as a control), we directly compared the phenotype of the mir-146a 3'F , mir-146a-null, and wild-type alleles, both in the context of homozygosity and heterozygosity.
Results

MiR-146a 3' pairing contributes to the regulation of target UTRs in vitro
We first utilized in vitro reporter assays to determine whether in this context miRNA "sensors" responded to ectopic miR-146a expression in a manner similar to UTRs that had previously been established to be miR-146a targets. To this end, we designed two synthetic miRNA duplexes: one identical to the duplex produced after cleavage of the wild-type mmu-mir-146a pre-miRNA by Dicer, and the other designed after the theoretical 3'F duplex (Supplemental Fig S2A) . The mutant sequence was modeled to reflect the mature (5ʹ) strand of a pre-miRNA in which positions 13-20 were made anti-complementary to their wild-type sequence. We reasoned that mutating to the anticomplement of the affected sequence would be the most deleterious to any potential physiological pairing by this region of the mature miRNA. Positions 9-12 within the mature miR-146a were left unperturbed under the rationale that these sequences were likely to be unpaired in a physiological setting (Schirle et al., 2014; Bartel, 2018) and positions 21-22 were conserved to lessen the chance that changes to loop-adjacent sequences might impact the processing or regulation of the resulting mutant.
We constructed luciferase reporter constructs containing six tandem MREs specifically tailored to match either of these mimics within the pRL-TK-CX6X backbone (Doench et al. 2003) . Thus, both the WT and 3'F mimics would perfectly base pair to their cognate reporter (with the exception of nt 10-13 to eliminate "slicer" activity), but only base-pair to their non-cognate reporter via nt 1-9 (Supplemental Fig S1A) . We transfected HeLa cells with these reporters, challenging each reporter separately with a series of concentrations of both the wild-type and mutant siRNA mimic duplexes.
In both cases, transfection of the mimic designed to pair to the reporter via both its seed region and the 3' region repressed reporter activity to a significantly greater degree than the mimic designed to pair only via the seed (Supplemental Figs S2B & C, . These data demonstrated that extensive 3' pairing has the potential to confer additional efficacy to miRNA function. However, since classically designed miRNA reporters such as those assessed here permit more extensive (or preclude the degree of) 3' pairing than is thought to generally occur in a physiological setting, we next asked whether a similar phenomenon might be observed using reporters containing the 3' UTRs of established miR-146a targets.
We thus repeated the reporter assay, this time targeting the 3' UTRs of the two originally characterized targets of miR-146a, Irak1 and Traf6 (Taganov et al. 2006 ). Alignment of the 3'F miR-146a sequence with the known MREs in both targets predicted substantial disruption of 3' base-pairing (Supplemental Fig S1B) . In keeping with this, we observed a modest but statistically significant (p<0.0001, two-way ANOVA) reduction in the ability of the 3'F mimic to repress both the Irak1 and Traf6 3' UTRs (Supplemental Figs S2D & E) . Taken together, these results support the notion that the 3' non-seed region of a miRNA positively contributes to target repression in vitro.
Construction and validation of a murine mir-146a 3'F allele
To determine whether the engineered "flip" mutation would be compatible with processing and expression from endogenous context, we synthesized and then subcloned the 3'F miR-146a precursor hairpin sequence into the 3' UTR of the pRL-TK-CX6X expression vector. Transfection of this vector into HEK 293 cells revealed that the 3'F pre-miRNA precursor was processed similarly to a similarly engineered wild-type miR-146a precursor in this context ( Fig 1A) . We therefore targeted the endogenous mir-146a allele in murine embryonic stem cells via homologous recombination to replace the wild-type mmu-mir-146a locus with the mutant 3'F sequence ( Fig   1B) . In parallel, we deleted the mir-146a sequence in a second embryonic stem cell line, generating a null allele to serve as a positive control for miR-146a's established phenotype ( Fig 1C-F and data not shown). Mice derived from these embryonic stem cell lines and homozygous for either mutant allele were born at Mendelian frequency with no discernable overt phenotypes.
To confirm that the mir-146a 3'F allele was expressed at similar levels to wild-type miR-146a, we compared the expression wild-type and 3'F miR-146a in several tissues and immune lineages derived from homozygous animals using qRT-PCR. Absolute values for miRNA expression in each sample were calculated via comparison to serial dilutions of synthetic standards cognate to each predicted mature miRNA sequence, and cross-priming analysis revealed a minimum of ~200fold specificity of each primer set for its respective target ( Fig 1G) . Absolute expression of the mature miR-146a 3'F miRNA in mir-146a 3'F/3'F homozygous mice was comparable to absolute expression of the wild-type mir-146a allele in homozygous wild-type mice in all tissues and cell populations examined ( Fig 1H) . As expected, neither wild-type nor 3'F miR-146a was detected in any tissues or cell populations derived from mir-146a -/mice ( Fig 1I and data not shown).
Comparison of lifespan, hematology, and autoimmunity
We next set out to characterize mice homozygous for the mir-146a 3'F allele in comparison to mir-146a null and wild-type animals, closely adhering to the workflow described in the initial published analysis of mir-146a deficiency (Boldin et al. 2011) . As previously described, miR-146a -/mice were marked by decreased long-term viability when compared to wild-type littermates, beginning at six to eight months of age (Fig 2A) . Gross analysis of mir-146a -/mice sacrificed during this period revealed marked splenomegaly (Fig 2B & C) and several signs of autoimmunity. Splenic T lymphocytes were characterized by increased basal activation on both CD4 + and CD8 + T lymphocytes, as defined by increased surface expression of CD69 and CD44 and decreased surface expression of CD62L. Spleens derived from mir-146a -/mice were also characterized by an increased GR-1 + CD11b + myeloid compartment, (Fig 2E, F) , and the serum of these mice were marked by an elevated titer of anti-double-stranded DNA antibodies ( Fig 2G) .
Also consistent with previous work, aged mir-146a -/mice (~14 mo) were characterized by marked decreases in hematocrit, red blood cell count, and platelet ( Fig 2H) . While we did not observe previously described reductions in the representation of white blood cells or hemoglobin at 14 months of age (Boldin et al. 2011) , our mir-146a -/line exhibited increases in mean corpuscular volume, mean platelet volume, hemoglobin distribution width, and red cell distribution width (Supplemental Fig S3) , consistent with anemia and bone marrow failure. Histological analysis of the liver and kidney of aged mice from our mir-146a -/line revealed increased infiltration of mononuclear inflammatory cells in both organs as compared to wild-type controls ( Fig 2I & J) . However, none of these phenotypes, whether previously described or novel to this study, were observed in aged mir-146a 3'F/3'F mice. Indeed, mir-146a 3'F/3'F mice were phenotypically indistinguishable from wild-type controls (Fig 2A-J) , whether at the previously described timepoints or when assessed again in the context of extremely advanced age (~125 weeks, or roughly 2.2 years, Fig 3) .
To better rule out the possibility that the mir-146a 3'F allele was modestly hypomorphic, we repeated this battery of experiments, this time comparing mir-146a 3'/hemizygotic mice to miR-146a +/controls. Once again, no statistically sufficient differences in phenotype were observed when these two lines were compared at the established time points, and no difference in longevity between the lines was observed out to 100 weeks (Fig 4) . Thus, for the phenotypes assessed, our data show that the mir-146a 3'F allele is functionally indistinguishable from the wild-type mir-146a allele.
Mir-146a-deficient, but not mir-146a 3'F/3'F mice, show hyper-responsiveness to LPS challenge.
Our findings above did not rule out the possibility that some difference in function might be observed by comparing the mir-146a and mir-146a 3'F alleles in the context of challenge of the innate immune machinery, either in vivo or in vitro. We thus assessed this possibility, again closely following the previously established experimental workflow. As previously described, following sublethal challenge via injection of lipopolysaccharide (LPS, 1mg/kg) mir-146a-deficient mice exhibited elevated levels of serum TNFα, IL-1β, and IL-6 as compared to wild-type controls ( Fig   5A) . Analogous results were observed after challenge with a lethal (35 mg/kg) dose of LPS -mir-146a-deficient mice were characterized by elevated levels of serum TNFα, IL-1β, and IL-6, and succumbed to the lethal LPS dose at a significantly greater rate than wild-type controls ( Fig S4) . Once again, repetition of these experiments with mir-146a +/and mir-146a 3'/mice revealed no significant differences in circulating cytokine levels or LPS sensitivity. Altogether, these results indicate that the mir-146a 3'F allele is essentially functionally equivalent to the wild-type mir-146a allele in these contexts.
To compare the function of the mutant and wild-type alleles in a cellular context, we challenged bone marrow derived macrophages (BMDMs) from each line with LPS ex vivo. Again, consistent with previously published results, BMDMs from miR-146a-deficient mice were characterized by comparatively increased production of IL-6 at eight and 16 hours following the LPS challenge ( Fig   5D) . This response coincided with increased relative expression of IRAK1 protein beginning at 16 hours post-challenge, consistent with the Irak1 mRNA's established role as a target of miR-146a (Figs 5E, F). Interestingly, we did not observe dysregulation of TRAF6 in any of our in vitro experiments (data not shown). While we noticed a modest trend for increased production of IL-6 by LPS-challenged mir-146a 3'F/3'F BMDMs, this did not reach statistical significance ( Fig 5D) and even this trend was significantly reduced when levels of IRAK1 protein were assessed (Figs 5E & F). Taken together, these data suggest that the mir-146a 3' allele may be modestly hypomorphic compared to the wild-type allele, but not to a degree that can be readily demonstrated.
Functional definition of miR-146a target spectrum and pairing rules in vivo
Having phenotypically assessed the function of the mir-146a allele within these contexts, we next wished to survey the transcriptome and proteome of mir-146a-deficient and mir-146a 3'F/3'F BMDMs relative to wild-type controls. Three biological replicates of BMDMs derived from each of the three genotypes were stimulated with 1 ng/ml LPS for 16 hours and harvested. Individual replicates were split into two fractionsone analyzed via next-generation sequencing and the other by label-free mass spectrometry proteome profiling.
Within mammalian systems, increased or decreased expression of a miRNA often correlates with a global shift in the relative expression of its predicted mRNA targets (Grimson et al. 2007 ).
However, this characteristic shift was absent, not only in the mir-146a 3'F/3'F BMDMs, but even in the mir-146a-deficient BMDMs when compared to wild-type controls. While differences of modest statistical significance were observed with lower target context scores (Grimson et al. 2007 ), the direction of these changes was opposite to what would be consistent with miRNA targeting, and no shift was observed for conserved miRNA targets ( Fig 6A and Supplemental Table   S1 ). This apparent lack of response at the transcript level has been previously reported for miR-146a (Boldin et al. 2011) . Because RNA-interference in mammals can mediate translational blockade without any appreciable effect on mRNA expression, we also looked for this target shift at the proteomic level using mass spectrometry-based profiling. No discernible shift in predicted miR-146a targets was seen at the protein level in either mir-146a 3'F/3'F or mir-146a-deficient BMDMs either ( Fig 6B and Supplemental Table 2 ). Indeed, only one protein -IRAK1that was predicted by TargetScan 7.1 (Agarwal et al. 2015) and/or present within miRDB (Wong & Wang 2015 ) was found to be upregulated relative to wild-type BMDMs in the mir-146a-deficient cells.
Of note, IRAK1's expression was not significantly different between wild-type and mir-146a 3'F /3'F BMDMs (Figs 5E, F and Supplemental Table S2 ).
Despite the fact that predicted miR-146a targets did not broadly increase in relative expression in mir-146a-deficient BMDMs, we did identify several proteins that did, and also many whose expression decreased relative to wild-type controls ( Supplemental Table S2 ). We manually examined those proteins whose change in expression following LPS stimulation in the mir-146adeficient BMDMs differed from those in wild-type by a Z-score greater than three, and we did not find any statistically significant enrichment for MREs complementary to miR-146a. This was true whether we looked for a perfect predicted hexamer seed match or allowed for the possibility of G::U wobble pairing (data not shown). However, given that a small number of mRNA transcripts falling into the differentially up-and down-regulated groups did contain MREs that would be predicted to bind miR-146a, we subcloned the respective 3' UTRs or segments of the coding sequence (as appropriate) of these genes of interest into the pRL-TK-CX6X reporter to test their responsiveness to miR-146a and miR-146a 3'F mimics. As a control, we also subcloned the 3' UTRs of strongly up-and down-regulated genes which lacked any recognized miR-146a target site. None of the predicted targets or negative controls responded to either mimic ( Fig 7A, multiple t-tests, FDR = 1%). Similar results were obtained when we assessed 3' UTRs of mRNAs containing miR-146a-complementary MREs and encoding proteins that differed in expression (Z-score > 3) between wild-type and mir-146a 3'F /3'F BMDMs ( Fig 7B) . These findings strongly argue against the possibility that differential protein expression of putative novel miR-146a and miR-146a 3'F targets is a direct effect of differential targeting by wild-type and mutant miRNA.
Discussion
We have characterized mutant mice in which the endogenous 3' pairing of miR-146a, an established regulator of NF-κB and innate immune signaling, is disrupted. By carefully revisiting the battery of experiments initially used to characterize mir-146a-deficient mice, we demonstrate here that the mir-146a 3'F allele recapitulates the function of wild-type miR-46a in each of the previously established phenotypes. Some non-significant trends towards the mir-146a-deficiency phenotype were noted in a comparison of mir-146a +/and mir-146a 3'F /mice and cells, and we were able to document a modest difference in dose-response to reporters under the control of the Irak1 and Traf6 3' UTRs. It is thus formally possible that the disruption of miR-146a's endogenous 3' pairing results in an allele that is very mildly hypomorphic, and that statistical significance would ultimately have been reached with greater numbers of mice. However, given that mir-146a 3'F /mice thus far (100 weeks at the time of writing) display indistinguishable health and longevity to mir-146a +/littermates, any decreased function appears to be quite modest.
Our findings stand at apparent odds with a large body of recent work demonstrating that many miRNAs engage their targets via 3' pairing, and that disruption of this pairing can negatively impact the regulatory relationship between a given miRNA and its mRNA target (Broughton et al. 2016; Chi et al. 2009 Chi et al. , 2012 Grosswendt et al. 2014; Hafner et al. 2010; Helwak et al. 2013; Loeb et al. 2012; Moore et al. 2015) . It should be noted, however, that while characterization of a murine allele allows for a comparatively robust assessment of multiple distinct phenotypes, this approach precludes the more systematic analyses that are possible in other model organisms or cell-based systems. We therefore consider it unwise at this juncture to make broad conclusions about the importance of miRNA 3' pairing in mammalian systems until additional work is made available.
A final and somewhat unexpected revelation from our study is our inability to detect a global shift in the relative expression of predicted miR-146a targets in either mir-146a-deficient or mir-146a 3'F /bone marrow-derived macrophages, whether at the level of the transcriptome or the proteome.
While similar conclusions have been drawn using different methods in an earlier analysis of the transcriptome of mir-146a-deficient mice (Boldin et al, 2011) , we were surprised that Irak1 was the only predicted miR-146a target whose changes in protein expression were consistent with mir-146a loss-of-function and rescue by the mir-146a 3'F allele. These findings would seem incongruous with a "micro-manager"-like regulatory role for miR-146a in the context examined, yet it should be noted that this regulatory role cannot be formally excluded with the data we present. Nonetheless, these data, when considered within the framework of the significant body of previous work on this general topic, support a nuanced view of miRNA target recognition and mechanism of action that may vary upon context, whether this context is species, the identity of the miRNA and its target, or cell state.
Materials & Methods
Generation of mir-146a KO and 3'F mice
A ~7.1 kb region of the Mus musculus genome from chromosome 11 was amplified in two arms.
Arm 1 (5.1 kb) was amplified from position 43,373,405 to 43,378,474 using primers 146_arm1_fw (5ʹ-atcgtaaagcttCCCAGGTACTGGGAAGAACA-3ʹ) and 146_arm1_rev (5ʹ-CACCTCAGCAGAC CATGCTA-3ʹ). Arm 2 (2.1 kb) was amplified from position 43,371,337-43,373,508 using primers 146a_arm2_fw (5ʹ-atcgtaggatccGAGAGACACAGGATTGCCAAGCAGTGATTTC-3ʹ) and 146a_ arm2_rev (5ʹ-atcgtagcggccgcCACTGGCTAAGGGTCGGATA-3ʹ). Arm 1, containing the mir-146a locus, was cloned into the HindIII site of the pIDT Smart™ ampicillin vector (IDT), and the WT mir-146a sequence was removed by cutting out a 536 nt region flanked by a BspHI recognition site at the 5' end and a BclI recognition site at the 3' end, then substituting in commercially synthesized sequences (IDT) either lacking the mir-146a gene sequence entirely or comprising the 3'F mutation.
Arm 2 (5' BamHI and 3' NotI) and the edited Arm 1 (HindIII) were then subcloned into the pBluescript™ II KS(+) (Addgene) vector on either side of a loxP-flanked region containing the neomycin resistance cassette. The resulting mir-146a 3'F and mir-146atargeting constructs were electroporated into V6.5 murine embryonic stem cells, and the colonies were grown and picked under standard G418/Gancyclovir double selection. Colonies derived from correctly recombined cells were identified via Southern analysis as described (Neilson et al. 2004 ). The Southern probes, amplified from genomic C57/BL6 genomic DNA corresponded to chr11: 43, 377, 378, 550 and chr11:43, 370, 371, 356 (both GRCm38/mm10) The G418 selection cassette was removed via transient transfection of Cre recombinase, and embryonic stem cells in which the cassette had been excised were identified via replicate plating in the presence and absence of G418. Correctly targeted embryonic stem cells were injected into C57BL6/J blastocysts to obtain chimeric mice and germline transmission. Heterozygous animals were intercrossed to obtain both mir-146a -/and mir-146a 3'F/3'F homozygotes.
Animal Studies
Transgenic founder animals from each line were individually backcrossed three times to the C57BL6/J line (Jackson) and breeding colonies were separately maintained for each line, utilizing heterozygotes for each mutant allele to produce paired homozygous mutant and wild-type control animals for each line. Age-and sex-matched mice from each of the two lines were utilized for all experiments (except where the use of sex-matched littermates is explicitly noted) such that homozygous mutants from each line were compared to an equivalent number of wild-type mice equally derived from the same two lines. No differences were noted in the phenotypic comparison of wild-type mice derived from breeding of mir-146a +/heterozygotes and wild-type mice derived from breeding of mir-146a 3'F /heterozygotes in any experiments. All mouse procedures were approved by the Institutional Animal Care and Use Committees of the Baylor College of Medicine.
Direct quantitation of WT and 3'F miR-146a
Liver, thymus, kidney, lymph nodes, spleen, and whole bone marrow were excised from age-and sex-matched WT, mir-146a-deficient, and mir-146a 3'F/3'F mice and physically disaggregated.
Splenocytes were separated into B cells and CD4 + and CD8 + T cells via flow sorting using a
FACSAria II (BD). Bone marrow cells were cultured for 1 week in either IL-4 (10 ng/mL) + GM-CSF (30 ng/mL) or M-CSF (10 ng/mL) (all R&D Systems) for differentiation to either bone marrow-derived dendritic cells (BMDCs) or bone marrow-derived macrophages (BMDMs), respectively. Differentiation was confirmed via flow cytometry using an LSR Fortessa (BD).
BMDMs and BMDCs were stimulated with 1 ng/mL LPS for 16 hours. RNA was isolated from all samples using TRIzol LS reagent (Life Technologies) as per the manufacturer's recommendations and quantified by spectrophotometry. Commercially obtained WT and 3'F miR-146a mimic direct quantification standards were serially diluted in 1 μg/mL total RNA derived from Drosophila S2 cells. Reverse transcription was performed with the miScript II RT kit (Qiagen) and qPCR was performed using the miScript SYBR ® Green PCR kit (Qiagen), both according to the manufacturer's instructions. Absolute miRNA quantification was calculated based on total input RNA for each biological sample. Primers specific for either the WT or the 3'F allele were used on all samples to ensure accurate genotyping and to rule out cross-priming.
Luciferase reporter constructs and luciferase assay
The 3' UTRs of indicated genes were amplified from mouse genomic DNA via PCR and subcloned into an edited version of the pRL-TK-CX6X Renilla luciferase reporter plasmid (Addgene) in which an endogenous miR-146a hexamer seed-complementary site within the Renilla luciferase CDS was removed via site-directed mutagenesis. XhoI and ApaI or NotI sites were respectively added to the 5' and 3' ends of the PCR amplicons to enable subcloning into these respective sites in the Renilla vector. Subsequent to restriction digestion, the amplicons were ligated with the vector using the NEB Quick Ligation ™ kit (NEB).
HeLa cells were seeded in 24 well plates at a seeding density of 40,000 cells/well in DMEM supplemented with L-glutamine, penicillin, streptomycin, sodium pyruvate, HEPES (pH 7.4), nonessential amino acids, and β-mercaptoethanol (DMEM complete) and allowed to grow overnight. The following day, the cells were transfected with the pGL3 Firefly luciferase control plasmid (Promega), one of the experimental Renilla luciferase reporter plasmids, and varying concentrations of either the WT or 3'F miRNA mimic duplexes (Sigma-Aldrich), along with a balanced amount of irrelevant anti-CXCR4 siRNA duplex (Sigma-Aldrich) to ensure that the final siRNA concentration in each well was always equal to 31.6 nM. Transfections were performed using the Lipofectamine 3000 transfection reagent system (Thermo Fisher) as per the manufacturer's protocol. Luciferase assays were performed using the Dual-Luciferase ® Reporter Assay System (Promega) as per the manufacturer's protocol on a Tecan M200 multimode reader using Tecan Magellan software (Tecan).
Splenic immunophenotyping
Spleens were excised, massed, photographed, and disaggregated. Red blood cells were lysed with ACK buffer, and the splenocyte suspensions were quantified prior to staining for the indicated markers. One million splenocytes were stained using a 1:100 dilution of fluorophore-tagged antibodies in 100 μL PBS + 1% FBS + 1 mM EDTA for 15 min at 4 °C, after which the cells were washed three times. Cell viability was ensured by staining with NucBlue ™ Live ReadyProbes ™ Reagent (Thermo Fisher). Cells heat-killed at 65 °C for 30 min were used as a control. Data was collected using a BD LSRFortessa flow cytometer and analyzed using Kaluza Analysis software V1.5 (Beckman Coulter).
Histological analysis
Livers and kidneys were excised to 70% ethanol and submitted to the Baylor College of Medicine Center for Comparative Medicine, where they were processed for hematoxylin and eosin staining via standard methods. Histological scoring was performed by a staff licensed veterinary pathologist blinded to the origin of the histological samples.
LPS challenges
For sublethal LPS challenges, mice were bled retro-orbitally and then stimulated with LPS at a dose of 1 mg/kg body mass. Mice were bled again at 2 hours and 24 hours post-injection. For lethal LPS challenges, mice were retro-orbitally bled and then stimulated with LPS at a dose of 35 mg/kg body mass. Mice were bled again at 6 h hours post-injection. Serum was collected from the blood via differential centrifugation at 9800 g for 7 min at 4 °C. IL-6 was quantified via commercial ELISA kit (R&D Systems) following the manufacturer's instructions. Other cytokines were quantified via Luminex assay (Thermo Fisher) by the Baylor College of Medicine Antibody-Based Proteomics core. For lethal LPS challenges, mice were monitored hourly for morbidity beginning at 10 hours post-injection.
CBC Analysis
Blood was collected via retro-orbital bleeding into EDTA-coated collection vials (BD Pharmingen) and submitted to the Baylor College of Medicine Center for Comparative Medicine.
Isolation and culture of BMDMs
Bone marrow from 6-7-month old mice was flushed from femurs and tibias and plated at 85,000 cells/cm 2 on non-tissue culture-treated petri dishes. The cells were cultured for 8-9 days in DMEM complete medium supplemented with M-CSF (10 ng/mL), with a medium change at day 3. Successful differentiation was verified by surface staining of CD11b, CD11c, F4/80, CD86, and GR-1, followed by flow cytometry analysis as described above.
In vitro BMDM LPS challenges
BMDMs were stimulated with 1 ng/mL LPS for 24 hrs. To allow monitoring of cytokine production specifically within various windows following stimulation, cell culture medium was collected and replaced with medium supplemented with 1 ng/mL LPS every 8 hrs following stimulation. Culture medium was snap frozen in liquid nitrogen and stored at -80 °C. Analysis of IL-6 content in the medium was carried out via commercial ELISA kit (R&D Systems) according to the manufacturer's instructions.
Immunoblots
BMDMs were lysed in RIPA buffer (10 mM Tris [pH 7.4], 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% Na-Desoxycholate, 1 mM EDTA, 1 mM DTT) containing protease and phosphatase inhibitors, snap frozen, and stored at -80 °C. Lysate protein concentration was quantified by the BCA protein assay. Forty μg of sample were diluted in 1X RIPA buffer, denatured in Laemmli buffer at 90 °C for 10 min, and loaded into a 4-12% polyacrylamide gel. Gels were transferred to a PVDF membrane at 30 V for 1 hr, blocked in 10% non-fat milk in TBST, then stained overnight at 4 °C with primary anti-IRAK1 (CST) and anti-GAPDH antibodies (EMD Millipore). The next day, the blots were washed three times with TBST, then incubated in HRP-conjugated secondary antibody for 30 min at room temperature. Blots were developed with ECL 2 solution (Thermo Fisher) and exposed to film.
RNA Seq
Total RNA was extracted using Trizol (Thermo Fisher) according to the commercial protocol. One hundred ng of total RNA was used for rRNA depletion using Ribo-Zero Gold rRNA removal kit (Illumina) and following a modified protocol for low inputs. Half of the rRNA-depleted RNA was used for library preparation using NEBNext Ultra II Directional RNA Library Prep Kit (New England Biolabs), followed by sequencing on a NextSeq500 instrument (Illumina). The raw reads were processed to remove the adapter sequences using cutadapt (v1.8.3) with the following arguments: −a GATCGGAAGAGCACACGTCTGAACTCCAGT, −m 20. Following adapter trimming, the reads originating from rRNA were removed by aligning the remaining reads to the rDNA using HISAT2 (v2.1.0) with the following arguments: −−no-spliced-alignment, −−un.
Reads that aligned to the rDNA were discarded. Remaining reads were aligned to the mouse genome (mm10) using HISAT2 (v2.1.0) with the following arguments: −−min-intronlen 70, −−rna-strandness R, −−known-splicesite-infile. The raw read counts were obtained for each gene (Gencode's comprehensive gene annotation release M15) using featureCounts (v1.5.3) with the following arguments: −s 2, −Q 50. For the miRNA targeting analysis, log2 fold-change of predicted targets of miR-146 (TargetScanMouse v7.1) were compared with the log2 fold-change of background set (mRNAs that do not contain miRNA target-sites in their 3' UTR). The significance of the difference was evaluated using Wilcoxon rank sum test. Raw RNAseq data may be obtained via NCBI GEO accession number GSE121232.
Mass spectrometry
Mass spectrometric analysis was carried out on an Orbitrap Fusion LumosETD (Thermo Fisher) by the Mass Spectrometry Proteomics core at Baylor College of Medicine as described before (Saltzman et al. 2018) . Briefly, BMDM lysates from 8-12-week old mice were denatured in ABC solution (50 mM ammonium bicarbonate + 1mM CaCl2), with subsequent snap freeze/42 °C thaw cycling and boil denaturing at 95 °C. The proteins were digested with a 1:20 solution of 1 μg/μL trypsin:protein overnight at 37 °C with shaking, and then with a 1:100 solution of 1 μg/μL trypsin:protein for 4 hours. The peptides were extracted and measured using the Pierce Quantitative Colorimetric Peptide Assay (Cat# 23275, Thermo Fisher Scientific). Next, 50 μg of vacuum-dried peptides were re-dissolved in pH10 ABC buffer (10 mM ammonium bicarbonate, pH 10, adjusted by NH4OH) and subjected to off-line microscaled reverse phase separation on a micropipette tip layered with 6 mg of C18 matrix (Reprosil-Pur Basic C18, 3 μm, Dr. Maisch GmbH) on top of a C18 disk plug (EmporeTM C18, 3M). A total of 15 (2-30% ACN, 2% steps) fractions were obtained and combined into 5 pools for mass spectrometry sequencing (15F5R protocol with 02+12+22, 04+14+24, 06+16+26, 08+18+28, and 10+20+30% combinations). For each run on the Lumos instrument, ~1 μg of peptide was loaded onto a 2 cm 100 μm ID pre-column and resolved on a 6 cm 150 μm ID column, both packed with sub-2 μm C18 beads (Reprosil-Pur Basic C18, Catalog #r119.b9.0003, Dr. Maisch GmbH). The gradient mobile phase was mixed from water (solution A) and 90% acetonitrile ( 
Putative novel miR-146a target identification
The difference in log2 fold-change of proteins upon LPS stimulation in the mass spectrometry analysis was calculated for WT and KO (and separately, WT and 3'F) BMDMs. The respective lists were sorted on this difference, and candidate targets were drawn from two pools of gene products with a Z score of >3 in the positive or negative direction from the median. Candidate novel targets were defined as those with a putative seed in the CDS or 3' UTR of the corresponding mRNA and characterized by a significant change (q < 0.05) in one or both of the genotypes compared. These candidates (along with negative controls characterized by differential expression but no predicted seed region) were amplified from murine genomic DNA via PCR and inserted into the pRL-TK-CX6X backbone, as described above.
Statistics
For comparisons between two groups, statistical significance was assessed using two-tailed All analyses performed on biological samples harvested from mice aged 217 ± 2 d unless otherwise indicated. Statistical comparisons made using unpaired two-tailed Student's t-test. (A) Dual luciferase assays of putative miR-146a targets characterized by differential protein expression following LPS stimulation in a comparison of KO and wild-type BMDMs. (B) Dual luciferase assays of putative miR-146a targets characterized by differential protein expression following LPS stimulation in a comparison of 3'F and wild-type BMDMs. Left: proteins with reduced expression in response to LPS in the 3'F BMDMs as compared to the wild-type BMDMs; Right: regions derived from proteins with reduced expression in response to LPS in the wild-type BMDMs as compared to the 3'F BMDMs.
Statistical comparisons were done using multiple Student's t-test. False discovery rate was set at 1%. * denotes statistical significance.
